BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 38537674)

  • 21. Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis.
    Wang L; He W; Wang X; Wang J; Wei X; Wu D; Wu Y
    Front Med (Lausanne); 2024; 11():1322102. PubMed ID: 38606153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
    Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
    Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.
    Bao H; Li J; Zhang B; Huang J; Su D; Liu L
    Front Immunol; 2023; 14():1113634. PubMed ID: 37090698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
    Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
    Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.